113 related articles for article (PubMed ID: 26735174)
1. The mitochondrial genetic landscape in neuroblastoma from tumor initiation to relapse.
Riehl LM; Schulte JH; Mulaw MA; Dahlhaus M; Fischer M; Schramm A; Eggert A; Debatin KM; Beltinger C
Oncotarget; 2016 Feb; 7(6):6620-5. PubMed ID: 26735174
[TBL] [Abstract][Full Text] [Related]
2. Targeted parallel DNA sequencing detects circulating tumor-associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma.
Riehl L; Mulaw M; Kneer K; Beer M; Beer A; Barth TF; Benes V; Schulte J; Fischer M; Debatin KM; Beltinger C
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1687. PubMed ID: 35899825
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.
Roth SA; Knutsen E; Fiskaa T; Utnes P; Bhavsar S; Hald ØH; Løkke C; Mestdagh P; Johansen SD; Flægstad T; Einvik C
Cancer Lett; 2016 Mar; 372(1):128-36. PubMed ID: 26708804
[TBL] [Abstract][Full Text] [Related]
4. Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients.
Nevo I; Oberthuer A; Botzer E; Sagi-Assif O; Maman S; Pasmanik-Chor M; Kariv N; Fischer M; Yron I; Witz IP
Int J Cancer; 2010 Apr; 126(7):1570-81. PubMed ID: 19739072
[TBL] [Abstract][Full Text] [Related]
5. Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression.
Rifatbegovic F; Frech C; Abbasi MR; Taschner-Mandl S; Weiss T; Schmidt WM; Schmidt I; Ladenstein R; Ambros IM; Ambros PF
Int J Cancer; 2018 Jan; 142(2):297-307. PubMed ID: 28921546
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance.
Fransson S; Martinez-Monleon A; Johansson M; Sjöberg RM; Björklund C; Ljungman G; Ek T; Kogner P; Martinsson T
Sci Rep; 2020 Dec; 10(1):22432. PubMed ID: 33384420
[TBL] [Abstract][Full Text] [Related]
7. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
[TBL] [Abstract][Full Text] [Related]
8. Single-cell next-generation sequencing of circulating tumor cells in patients with neuroblastoma.
Kojima M; Harada T; Fukazawa T; Kurihara S; Touge R; Saeki I; Takahashi S; Hiyama E
Cancer Sci; 2023 Apr; 114(4):1616-1624. PubMed ID: 36571449
[TBL] [Abstract][Full Text] [Related]
9. Level of Seven Neuroblastoma-Associated mRNAs Detected by Droplet Digital PCR Is Associated with Tumor Relapse/Regrowth of High-Risk Neuroblastoma Patients.
Thwin KKM; Ishida T; Uemura S; Yamamoto N; Lin KS; Tamura A; Kozaki A; Saito A; Kishimoto K; Mori T; Hasegawa D; Kosaka Y; Nino N; Takafuji S; Iijima K; Nishimura N
J Mol Diagn; 2020 Feb; 22(2):236-246. PubMed ID: 31837427
[TBL] [Abstract][Full Text] [Related]
10. Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations.
Pastorino F; Capasso M; Brignole C; Giglio S; Bensa V; Cantalupo S; Lasorsa VA; Tondo A; Mura R; Sementa AR; Garaventa A; Ponzoni M; Amoroso L
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232538
[TBL] [Abstract][Full Text] [Related]
11. Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma.
Schramm A; Köster J; Marschall T; Martin M; Schwermer M; Fielitz K; Büchel G; Barann M; Esser D; Rosenstiel P; Rahmann S; Eggert A; Schulte JH
Int J Cancer; 2013 Feb; 132(3):E106-15. PubMed ID: 22907398
[TBL] [Abstract][Full Text] [Related]
12. Mutational dynamics between primary and relapse neuroblastomas.
Schramm A; Köster J; Assenov Y; Althoff K; Peifer M; Mahlow E; Odersky A; Beisser D; Ernst C; Henssen AG; Stephan H; Schröder C; Heukamp L; Engesser A; Kahlert Y; Theissen J; Hero B; Roels F; Altmüller J; Nürnberg P; Astrahantseff K; Gloeckner C; De Preter K; Plass C; Lee S; Lode HN; Henrich KO; Gartlgruber M; Speleman F; Schmezer P; Westermann F; Rahmann S; Fischer M; Eggert A; Schulte JH
Nat Genet; 2015 Aug; 47(8):872-7. PubMed ID: 26121086
[TBL] [Abstract][Full Text] [Related]
13. Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells.
Degli Esposti C; Iadarola B; Maestri S; Beltrami C; Lavezzari D; Morini M; De Marco P; Erminio G; Garaventa A; Zara F; Delledonne M; Ognibene M; Pezzolo A
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915956
[TBL] [Abstract][Full Text] [Related]
14. Growth, progression and chromosome instability of Neuroblastoma: a new scenario of tumorigenesis?
Tonini GP
BMC Cancer; 2017 Jan; 17(1):20. PubMed ID: 28056863
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma.
Calabrese FM; Clima R; Pignataro P; Lasorsa VA; Hogarty MD; Castellano A; Conte M; Tonini GP; Iolascon A; Gasparre G; Capasso M
Oncotarget; 2016 Aug; 7(31):49246-49258. PubMed ID: 27351283
[TBL] [Abstract][Full Text] [Related]
16. Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma.
Modak S; Asante-Korang A; Steinherz LJ; Grana N
J Pediatr Hematol Oncol; 2015 Aug; 37(6):e381-3. PubMed ID: 26181424
[TBL] [Abstract][Full Text] [Related]
17. Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.
Hunter SM; Rowley SM; Clouston D; ; Li J; Lupat R; Krishnananthan N; Risbridger G; Taylor R; Bolton D; Campbell IG; Thorne H
Urol Oncol; 2016 Mar; 34(3):120.e9-16. PubMed ID: 26585945
[TBL] [Abstract][Full Text] [Related]
18. Pilot study to evaluate MYCN expression as a neuroblastoma cell marker to detect minimal residual disease by RT-PCR.
Wagner LM; Burger RA; Guichard SM; Raimondi SC; Santana VM; Furman WL; Barnette P; Danks MK
J Pediatr Hematol Oncol; 2006 Oct; 28(10):635-41. PubMed ID: 17023822
[TBL] [Abstract][Full Text] [Related]
19. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.
Altungoz O; Aygun N; Tumer S; Ozer E; Olgun N; Sakizli M
Cancer Genet Cytogenet; 2007 Jan; 172(2):113-9. PubMed ID: 17213019
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Mutation Profiling Changes before and 3 Weeks after Chemotherapy in Newly Diagnosed Breast Cancer Patients.
Tan SH; Sapari NS; Miao H; Hartman M; Loh M; Chng WJ; Iau P; Buhari SA; Soong R; Lee SC
PLoS One; 2015; 10(12):e0142466. PubMed ID: 26630576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
